MedTrace Logo

Kimchi Powder on Gut Health

NCT07749092 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-06

No results posted yet for this study

Summary

The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Kimchi powder supplementation on gut health in adults with diarrhea-predominant irritable bowel syndrome (IBS-D) for 8 weeks.

Conditions

  • Irritable Bowel Syndrome - Diarrhoea

Interventions

DIETARY_SUPPLEMENT

Kimchi power

Kimchi powder in capsule form, 3,000 mg/day of kimchi powder (total 3,600 mg/day as capsules), taken orally in three divided doses after meals for 8 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo capsules identical in appearance and packaging to the test product, containing lactose and other excipients, total 3,600 mg/day, taken orally in three divided doses after meals for 8 weeks.

Sponsors & Collaborators

  • Pusan National University Yangsan Hospital

    lead OTHER

Principal Investigators

  • Sang Yeoup Lee, MD, PhD · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-03
Primary Completion
2027-12-30
Completion
2027-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07749092 on ClinicalTrials.gov